• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Nick Gallo

Finance

Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact

May 8, 2024 Nick Gallo

The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and […]

Phytobiome & Environment

A virus could help save billions of gallons of wastewater produced by fracking

May 8, 2024 Nick Gallo

An estimated 168 billion gallons of wastewater — or produced water — is generated annually by the Permian Basin fracking industry, according to a 2022 report by the Texas Produced Water Consortium. The major waste stream has […]

Finance

Lallemand Health Solutions and dsm-firmenich: New Partnership for Early-Life Synbiotic Solutions

April 24, 2024 Nick Gallo

Lallemand Health Solutions and dsm-firmenich are joining forces to launch early-life synbiotic solutions, leveraging the synergy of probiotics and human milk oligosaccharides (HMOs). Unlocking the synergy between probiotics and HMOs to provide infants with the […]

Pharma & Human Health

Millions of gamers advance biomedical research

April 23, 2024 Nick Gallo

Leveraging gamers and video game technology can dramatically boost scientific research according to a new study published on April 15th in Nature Biotechnology. 4.5 million gamers around the world have advanced medical science by helping […]

Finance

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

April 22, 2024 Nick Gallo

SNIPR Biome ApS (“SNIPR”), the company pioneering the development of precision medicines using CRISPR technology for microbial gene therapy, announces today that it has received $5.48 million from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (“CARB-X”) to […]

Pharma & Human Health

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002

April 16, 2024 Nick Gallo

MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease indication Pouchitis. […]

Pharma & Human Health

AI powered “digital twin” models the infant microbiome

April 15, 2024 Nick Gallo

Researchers at the University of Chicago have developed a new generative artificial intelligence (AI) tool that models the infant microbiome. This “digital twin” of the infant microbiome creates a virtual model that predicts the changing […]

Pharma & Human Health

New enzymatic cocktail can kill tuberculosis-causing mycobacteria

April 15, 2024 Nick Gallo

With resistance to chemical antibiotics on the rise, the world needs entirely new forms of antibiotics. A new study published in Microbiology Spectrum, a journal of the American Society for Microbiology, shows that an enzymatic cocktail […]

Animal Health

Nestlé translates analysis of pet’s gut microbiome data into tailored nutrition and supplement recommendation

April 5, 2024 Nick Gallo

Nestlé’s recently launched Petivity Microbiome Analysis Kit in the U.S. helps to deliver tailored nutrition and supplement recommendations for dogs and cats based on their unique gut profile. Through science-based sequencing technology of a pet’s microbiome, the new analysis […]

Finance

EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS

April 4, 2024 Nick Gallo

EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced that the Company has completed its £27m ($34m USD) funding round, supported by new and existing investors. The funding will […]

Posts navigation

« 1 2

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
sign up

Sign up to the Microbiome Times newsletter